These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2506523)

  • 1. A comparison of the effects and interactions of cromakalim and glibenclamide in cardiac and vascular tissues.
    BoSmith RE; Briggs I; Grant TL; Grimwood S; Russell NJ; Stone MA; Wickenden AD
    Pflugers Arch; 1989; 414 Suppl 1():S190. PubMed ID: 2506523
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs.
    Zografos P; Li JH; Kau ST
    Pharmacology; 1992; 45(4):216-30. PubMed ID: 1438528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
    Matsuda T; Okazaki K; Kato Y; Tanaka H; Shigenobu K
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):608-13. PubMed ID: 8569223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of the K(+)-channel openers cromakalim and minoxidil sulphate on vascular smooth muscle.
    Wickenden AD; Grimwood S; Grant TL; Todd MH
    Br J Pharmacol; 1991 May; 103(1):1148-52. PubMed ID: 1878752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of BRL 38227 on K-currents in rat portal vein.
    Edwards G; Noack T; Deitmer P; Weston AH
    Jpn J Pharmacol; 1992; 58 Suppl 2():336P. PubMed ID: 1507585
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the relaxing effects of cicletanine and cromakalim on vascular smooth muscle.
    Deitmer P; Golenhofen K; Noack T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):35-42. PubMed ID: 1383629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
    Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
    Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of racemic cromakalim, BRL 38226 and levcromakalim on the membrane potential of the rat aorta and of BRL 38226 on the contractile activity of the rat aorta and portal vein.
    Bishop BE; Doggrell SA
    J Auton Pharmacol; 1994 Apr; 14(2):99-108. PubMed ID: 8051202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR; Li YQ; Wyse DG
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract]   [Full Text] [Related]  

  • 12. Tedisamil (KC 8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim.
    Bray K; Quast U
    Eur J Pharmacol; 1991 Jul; 200(1):163-5. PubMed ID: 1769368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel modulation in rat portal vein by ATP depletion: a comparison with the effects of levcromakalim (BRL 38227).
    Noack T; Edwards G; Deitmer P; Weston AH
    Br J Pharmacol; 1992 Dec; 107(4):945-55. PubMed ID: 1467843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of BRL 38227 on potassium currents in smooth muscle cells isolated from rabbit portal vein and human mesenteric artery.
    Russell SN; Smirnov SV; Aaronson PI
    Br J Pharmacol; 1992 Mar; 105(3):549-56. PubMed ID: 1628142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein.
    Masuda Y; Arakawa C; Yamashita T; Miyajima M; Shigenobu K; Kasuya Y; Tanaka S
    Eur J Pharmacol; 1991 Apr; 195(3):323-31. PubMed ID: 1831135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
    Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.
    McCullough JR; Normandin DE; Conder ML; Sleph PG; Dzwonczyk S; Grover GJ
    Circ Res; 1991 Oct; 69(4):949-58. PubMed ID: 1934346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
    Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single channel and whole-cell K-currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein.
    Beech DJ; Zhang H; Nakao K; Bolton TB
    Br J Pharmacol; 1993 Oct; 110(2):583-90. PubMed ID: 8242233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.